Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 24
Filter
Add more filters











Publication year range
1.
Food Chem Toxicol ; 40(4): 487-500, 2002 Apr.
Article in English | MEDLINE | ID: mdl-11893408

ABSTRACT

Toxicological effects of dietary soy trypsin inhibitor (TI) were assessed in male miniature swine, a model chosen for its similarities to human digestive physiology and anatomy. The TI preparation was extracted from defatted raw soy flour. From 1 through 5 weeks of age, piglets were automatically fed either a TI liquid diet [Autosow TI group (ASTI)] or a control liquid diet [Autosow control group (ASC)]. From 6 to 39 weeks of age, these animals received either swine chow and TI or swine chow and control article. The TI diets were formulated to contain a TI activity of approximately 500 mg TI/100 g dry matter. A sow control (SC) group suckled from birth to 6 weeks of age and then fed as the ASC group with swine chow plus control article from 6 to 39 weeks of age. The SC piglets grew faster than ASC piglets during postnatal weeks 1 and 2; however, the ASC piglets were significantly heavier than the SC piglets (P=0.001) at 6 weeks of age. Compared with the ASC group, TI caused a moderate decrease in feed consumption and a moderate but reversible decrease in growth from 2 to 5 weeks of age, but not thereafter. Some control and TI-fed Autosow-reared piglets had loose stools until 6 weeks of age; the effect was significantly greater in the TI-fed group. Otherwise, all swine were active and had normal appearance and behavior.


Subject(s)
Disease Models, Animal , Plant Proteins/adverse effects , Soybean Proteins/chemistry , Administration, Oral , Animal Feed , Animals , Animals, Newborn/growth & development , Diarrhea/etiology , Diarrhea/veterinary , Diet , Feeding Behavior , Female , Male , Swine , Trypsin Inhibitors , alpha-Amylases/antagonists & inhibitors
2.
Food Chem Toxicol ; 40(4): 501-16, 2002 Apr.
Article in English | MEDLINE | ID: mdl-11893409

ABSTRACT

The potential toxicity of dietary soy trypsin inhibitor (TI) was evaluated in neonatal miniature swine. From 1 to 6 weeks of age, two groups of male piglets were artificially reared in an Autosow and automatically fed either TI or control liquid diet. From 6 to 39 weeks of age, these two groups were fed either TI or control chow diet. A third group, sow control (SC), suckled from birth to 6 weeks of age, were also weaned to control chow from 6 to 39 weeks of age. Clinical chemistry and plasma cholecystokinin (CCK) determined at 6, 18, 30 and 39 weeks of age, and serum amylase activity with gross and histopathological analyses of major organs at 6 and 39 weeks of age are reported. TI had no effect on plasma CCK, serum amylase activity, or numerous clinical chemistry values. TI-fed piglets had a larger relative liver weight at 6 weeks of age. Relative pancreas weight decreased with age but was not affected by TI. Gross and histopathological analyses of major organs, except the spleen, were within normal limits. Increased incidence of extramedullary hematopoiesis was noted in the spleen of the TI group at 6 but not at 39 weeks of age. There was no consistent pattern in immunohistochemical foci for secretin, gastrin releasing polypeptide or CCK, and no change in DNA, RNA, mitotic index or nuclear density of pancreatic cells. At 6 weeks of age, TI increased pancreatic protein and amylase activity but not trypsin or chymotrypsin activity. None of the effects suggested that this dose of TI was toxic to either the neonatal or sexually mature miniature male swine.


Subject(s)
Cholecystokinin/blood , Plant Proteins/adverse effects , Soybean Proteins/chemistry , Administration, Oral , Amylases/metabolism , Animal Feed , Animals , Animals, Newborn/growth & development , Body Weight , Cell Cycle , DNA/analysis , Immunohistochemistry , Liver/pathology , Male , Pancreas/enzymology , Pancreas/pathology , Plant Proteins/administration & dosage , RNA/analysis , Swine , Trypsin Inhibitors , alpha-Amylases/antagonists & inhibitors
3.
J Nutr Sci Vitaminol (Tokyo) ; 47(3): 201-12, 2001 Jun.
Article in English | MEDLINE | ID: mdl-11575575

ABSTRACT

There are an overwhelming number of reports indicating the beneficial effects of fish oil supplements in human and animal nutrition. The purpose of this study, second in a series, was to evaluate the effects, particularly those that may be harmful, of high-dose, long-term consumption of fish oil concentrates (FOC) using male and female rats. One hundred and twenty male and 120 female rats were gavaged daily with oils and oil mixtures in a volume equal to 0.5% body weight (5 mL/kg/d) for 13 weeks. The administered oils were corn oil, pure menhaden oil (MO), pure MaxEPA fish oil or different mixtures of corn oil with MO. The stability and the homogeneity of the dosing solutions were tested under study conditions. The animals received isocaloric and isonitrogenous diets throughout. Food and pure water were supplied ad libitum. At the end of the in-life phase of the study, the animals were anaesthetized with CO2 and humanely killed by exsanguination. Blood and other tissues were prepared for various clinical, histopathological and laboratory tests. Some beneficial effects of FOC, such as reduction in total serum cholesterol, in rats were confirmed. However, we also observed a significant reduction in absolute amount of serum HDL and a significant increase in relative liver and spleen weights in both sexes with the high dose of FOC. High doses of FOC (5 mL/kg/d) reduced serum iron and vitamin E concentrations. A reduction in osmotic fragility of RBC as well as an increase in RBC deformity were also observed in rats treated with high doses of FOC. These rats showed a significant overall increase in WBC count. We conclude that in rats, subchronic consumption of high levels of FOC can be beneficial but may also be harmful because of induction of clinical abnormalities including increased red cell deformity, increased relative liver and spleen weights, and reduced serum HDL, iron and vitamin E concentrations.


Subject(s)
Dietary Fats, Unsaturated/toxicity , Fatty Acids, Omega-3/blood , Fish Oils/toxicity , Animals , Cholesterol/blood , Cholesterol, HDL/blood , Corn Oil/toxicity , Dietary Supplements/toxicity , Dose-Response Relationship, Drug , Erythrocytes , Female , Iron/blood , Male , Organ Size/drug effects , Rats , Rats, Sprague-Dawley , Vitamin E/blood
4.
J AOAC Int ; 84(3): 919-35, 2001.
Article in English | MEDLINE | ID: mdl-11417655

ABSTRACT

We examined a number of large proficiency and control databases supporting the values reported for pesticide residues in agricultural commodities at fractions of a part per million (mg/kg). The average recovery from >100,000 recovery records in 13 databases was 94%. The overall average single-value relative standard deviation (RSD) of the reported recoveries was 17% at a mean concentration (C) of about 10(-7) (0.1 mg/kg). The average apparent HORRAT value (RSD found/RSDR predicted from the Horwitz formula [2*C(-0.1505)]) was 0.8. Analysis of variance indicated that about 60-70% of the variance could not be associated with any particular factor or combination of factors-analyte, commodity, method, laboratory, concentration, database, or their interactions. The most predominant factor, analyte, and its third-order interaction with laboratory and concentration contributed most of the assignable variance. These findings suggested that most of the variability of trace analysis for pesticide residues is "random" in the sense of being inherent and not assignable to specific factor fluctuations.


Subject(s)
Crops, Agricultural/chemistry , Food Analysis/standards , Pesticide Residues/analysis , Analysis of Variance , California , Fruit , Laboratories/standards , Quality Control , United States , United States Department of Agriculture , Vegetables
5.
Metabolism ; 49(4): 508-12, 2000 Apr.
Article in English | MEDLINE | ID: mdl-10778877

ABSTRACT

We previously showed that chronic ethanol feeding leads to a decrease of apolipoprotein E (apoE) in high-density lipoprotein (HDL), whereas supplementing this diet with 2.8% of total dietary calories as omega3-fatty acids (omega3FAs) restores HDL-apoE to the control values. Since HDL containing apoE plays a major role in reverse cholesterol transport (RCT), we measured the effects chronic ethanol intake and omega3-FAs on RCT in the present study. Four groups of rats, control normal fat (CN), alcohol-normal fat (AN), control omega3FA fat (CF), and alcohol-omega3FA fat (AF), were fed their respective diets for 8 weeks, after which hepatocytes and HDLs from each group were evaluated for RCT capacity (cholesterol efflux from macrophages and uptake by liver cells). Compared with the control diet (CN), chronic ethanol (AN) feeding inhibited the cholesterol efflux capacity of HDL by 21% (P < .01), whereas omega3FA feeding (2.8% of total dietary calories) stimulated this capacity by 79% (P < .01) and 25% (P < .01) in CF and AF rats, respectively. With respect to cholesterol uptake by the liver, there were no significant 3-way or 4-way interactions between the 4 factors, HDL-alcohol, HDL-fish oil, hepatocyte-alcohol, and hepatocyte-fish oil. The main effects for HDL-alcohol, HDL-fish oil, and hepatocyte-alcohol were all highly significant (P = .0001, .0001, and .007, respectively). There was a significant HDL-alcohol and HDL-fish oil interaction (P = .0001). Hepatocyte-alcohol was not a factor in any 2-way interactions. Our study indicates no evidence of an interaction between the effects of omega3FAs and the effects of alcohol on hepatocytes in terms of RCT function. Thus, feeding as little as 2.8% of the total dietary calories as omega3FA not only restored the impaired RCT function of HDL caused by chronic ethanol intake, but also enhanced by severalfold the ability of HDL to promote RCT even in normal animals.


Subject(s)
Cholesterol/metabolism , Dietary Fats/pharmacology , Ethanol/pharmacology , Fatty Acids, Omega-3/pharmacology , Administration, Oral , Animals , Biological Transport, Active/drug effects , Cells, Cultured , Liver/cytology , Liver/metabolism , Macrophages/metabolism , Male , Mice , Rats , Rats, Inbred WF , Time Factors
6.
J Nutr Sci Vitaminol (Tokyo) ; 45(5): 553-65, 1999 Oct.
Article in English | MEDLINE | ID: mdl-10683808

ABSTRACT

Many studies suggest that a diet supplemented with fish oil concentrates (FOCs) may provide protection against cardiovascular and other diseases. The possible harmful effects of long-term consumption of high doses of FOCs, however, have not been adequately investigated. Corn oil, fish oil (MaxEPA) and various mixtures of the oils were administered by gavage to 120 male and 120 female rats, 5 d/wk for 13 wk at the rate of 5 mL/kg/d. Although MaxEPA had no effect on prothrombin time or activated partial thromboplastin time, it caused a statistically significant diminution of the total serum cholesterol level. Correlations between relative liver and spleen weights and dose levels were positive but a negative correlation was found between dose levels and serum vitamin E concentration. In female rats, the negative correlations between dose levels and serum iron and triglyceride levels were highly significant. The pathology data showed no remarkable lesions in any of the tissues examined. Results of this study suggest that long-term consumption of high levels of FOCs in rats may reduce serum cholesterol and triglycerides and adversely affect serum iron level and relative liver weight in female rats and relative spleen weights in both sexes.


Subject(s)
Dietary Fats, Unsaturated/administration & dosage , Dietary Fats, Unsaturated/adverse effects , Fish Oils/administration & dosage , Fish Oils/adverse effects , Animals , Cholesterol/blood , Corn Oil/administration & dosage , Female , Iron/blood , Liver/anatomy & histology , Male , Organ Size , Partial Thromboplastin Time , Prothrombin Time , Rats , Rats, Sprague-Dawley , Sex Characteristics , Spleen/anatomy & histology , Triglycerides/blood
7.
J AOAC Int ; 81(6): 1257-65, 1998.
Article in English | MEDLINE | ID: mdl-9850588

ABSTRACT

Large-scale laboratory- and method-performance studies involving more than about 30 laboratories may be evaluated by calculating the HORRAT ratio for each test sample (HORRAT = [experimentally found among-laboratories relative standard deviation] divided by [relative standard deviation calculated from the Horwitz formula]). The chemical analytical method is deemed acceptable per se if HORRAT approximately 1.0 (+/- 0.5). If HORRAT is > or approximately 2.0, the most extreme values are removed successively until an "acceptable" ratio is obtained. The laboratories responsible for the extreme values that are removed should examine their technique and procedures. If > or approximately 15% of the values have to be removed, the instructions and the methods should be examined. This suggested computation procedure is simple and does not require statistical outlier tables. Proposed action limits may be adjusted according to experience. Data supporting U.S. Environmental Protection Agency method 245.1 for mercury in waters (manual cold-vapor atomic absorption spectrometry), supplemented by subsequent laboratory-performance data, were reexamined in this manner. Method-performance parameters (means and among-laboratories relative standard deviations) were comparable with results from the original statistical analysis that used a robust biweight procedure for outlier removal. The precision of the current controlled performance is better by a factor of 4 than that of estimates resulting from the original method-performance study, at the expense of rejecting more experimental values as outliers.


Subject(s)
Chemistry Techniques, Analytical/statistics & numerical data , Laboratories , Statistics as Topic/methods , Chemistry Techniques, Analytical/methods , Chemistry Techniques, Analytical/standards , Mercury/analysis , Quality Control , United States , United States Environmental Protection Agency , Water/analysis
8.
Appl Environ Microbiol ; 64(4): 1459-65, 1998 Apr.
Article in English | MEDLINE | ID: mdl-9546182

ABSTRACT

This study investigated the temperature and salinity parameters associated with waters and oysters linked to food-borne Vibrio vulnificus infections. V. vulnificus was enumerated in oysters collected at three northern Gulf Coast sites and two Atlantic Coast sites from July 1994 through September 1995. Two of these sites, Black Bay, La., and Apalachicola Bay, Fla., are the source of the majority of the oysters implicated in V. vulnificus cases. Oysters in all Gulf Coast sites exhibited a similar seasonal distribution of V. vulnificus: a consistently large number (median concentration, 2,300 organisms [most probable number] per g of oyster meat) from May through October followed by a gradual reduction during November and December to < or = 10 per g, where it remained from January through mid-March, and a sharp increase in late March and April to summer levels. V. vulnificus was undetectable (< 3 per g) in oysters from the North and South Carolina sites for most of the year. An exception occurred when a late-summer flood caused a drop in salinity in the North Carolina estuary, apparently causing V. vulnificus numbers to increase briefly to Gulf Coast levels. At Gulf Coast sites, V. vulnificus numbers increased with water temperatures up to 26 degrees C and were constant at higher temperatures. High V. vulnificus levels (> 10(3) per g) were typically found in oysters from intermediate salinities (5 to 25 ppt). Smaller V. vulnificus numbers (< 10(2) per g) were found at salinities above 28 ppt, typical of Atlantic Coast sites. On 11 occasions oysters were sampled at times and locations near the source of oysters implicated in 13 V. vulnificus cases; the V. vulnificus levels and environmental parameters associated with these samples were consistent with those of other study samples collected from the Gulf Coast from April through November. These findings suggest that the hazard of V. vulnificus infection is not limited to brief periods of unusual abundance of V. vulnificus in Gulf Coast oysters or to environmental conditions that are unusual to Gulf Coast estuaries.


Subject(s)
Ostreidae/microbiology , Shellfish/microbiology , Vibrio/isolation & purification , Animals , Colony Count, Microbial , Foodborne Diseases/etiology , Humans , Seasons , Sodium Chloride/analysis , Southeastern United States , Temperature , Vibrio/pathogenicity , Vibrio Infections/etiology , Water Microbiology
9.
Peptides ; 18(2): 277-85, 1997.
Article in English | MEDLINE | ID: mdl-9149301

ABSTRACT

Substance P (SP, 1 microM) when incubated with minced von Ebner's glands for 15, 30, and 60 min, stimulated secretion of lingual lipase (12.14% +/- 0.90) and amylase (8.30% +/- 0.42). Only 10 microM of the SP receptor antagonist CP-96,345 significantly inhibited SP-evoked secretion. D-Pro2-D-Phe7-D-Trp9-SP (Ia), D-Pro2-D-Trp7,9-SP (Ib), D-Arg1-D-Trp7,9-D-Leu11-SP (Ic), or 1 microM CP-96,345 were not effective, suggesting that the SP receptor of von Ebner's gland might be an isoform. Propranolol and timolol, beta 1/beta 2-adrenergic receptor antagonists were not effective and the cholinergic receptor antagonist, atropine, was effective in only slightly reducing amylase secretion but not lingual lipase. Differential secretion of the two enzymes was observed for basal and stimulated secretion. Thus, exocytosis may not be the only pathway involved in SP-evoked protein secretion.


Subject(s)
Amylases/metabolism , Biphenyl Compounds/pharmacology , Lipase/metabolism , Neurokinin-1 Receptor Antagonists , Salivary Glands/enzymology , Substance P/analogs & derivatives , Substance P/pharmacology , Tongue/physiology , Animals , Atropine/pharmacology , Kinetics , Male , Propranolol/pharmacology , Rats , Rats, Sprague-Dawley , Salivary Glands/drug effects , Substance P/antagonists & inhibitors , Time Factors , Timolol/pharmacology , Tongue/drug effects
10.
Food Chem Toxicol ; 35(12): 1135-41, 1997 Dec.
Article in English | MEDLINE | ID: mdl-9449218

ABSTRACT

Aminopentol (AP1) is the total hydrolysis product of fumonisin B1 (FB1), the major and best characterized of the fumonisins, which are mycotoxins that are common contaminants of corn and corn meal. Some human populations expected to have significant exposure to AP1 have a high incidence of babies born with neural tube defects (NTD). The embryotoxicity of AP1 was evaluated in cultured rat embryos. Gestation day 9.5 embryos were exposed to 0, 3, 10, 30, 100 or 300 microM AP1 throughout the entire 45-hr culture period. At 100 microM AP1, growth and overall development were reduced significantly. There was also a significant increase in the incidence of abnormal embryos. 29% of the embryos had NTD, and 36% of the embryos had other abnormalities. At 300 microM AP1, the incidence of NTD was 15%, and 85% of the embryos had other abnormalities. These findings suggest that AP1, at concentrations of 100 microM and above, can induce NTD in organogenesis-stage cultured rat embryos. However, these NTD are in conjunction with significant overall retardation of growth and development as well as significant increases in the incidence of other defects. These studies also showed, when compared with previous findings, that AP1 is over 100-fold less toxic than FB1 to cultured rat embryos.


Subject(s)
Abnormalities, Drug-Induced , Carboxylic Acids/toxicity , Embryo, Mammalian/drug effects , Fumonisins , Mycotoxins/toxicity , Teratogens/toxicity , Animals , Carboxylic Acids/chemistry , Embryonic and Fetal Development/drug effects , Environmental Exposure , Female , Morphogenesis , Mycotoxins/chemistry , Neural Tube Defects/chemically induced , Organ Culture Techniques , Rats , Rats, Sprague-Dawley , Teratogens/chemistry
11.
Br J Nutr ; 75(6): 915-28, 1996 Jun.
Article in English | MEDLINE | ID: mdl-8774236

ABSTRACT

The purpose of the present study was to determine the effects of feeding nutritionally adequate and increased levels of vitamin A (retinyl acetate at 1.4, 34.4, and 206.4 mg/kg diet) in combination with adequate or increased Zn (12 and 240 mg/kg) and Cu (5 and 50 mg/kg) on serum and tissue concentrations of retinol and retinyl palmitate and on indices of Cu and Zn status in female Sprague-Dawley rats, and to measure interactive effects of such nutrient imbalances. Rats fed on diets containing 34.4 and 206.4 mg vitamin A/kg had higher feed intakes and relative liver weights than those fed on diets containing 1.4 mg vitamin A/kg. An interaction between dietary Cu and Zn and an independent effect of vitamin A affected serum ceruloplasmin oxidase (EC 1.16.3.1) activity. Rats fed on high Zn, adequate-Cu diets (240 and 5 mg Zn and Cu/kg respectively) had lower serum ceruloplasmin oxidase levels than rats fed on adequate-Zn, adequate-Cu diets (12 and 5 mg Zn and Cu/kg respectively). This effect was not observed in rats fed on high-Zn, high-Cu diets (240 and 50 mg Zn and Cu/kg respectively). Alterations in dietary levels of Cu and vitamin A independently affected haemoglobin levels. Serum cholesterol concentration was affected by interactions between Zn and vitamin A and Cu and vitamin A. Levels of retinol and retinyl palmitate in liver and kidney were significantly higher in rats fed on diets with increased dietary vitamin A than in those fed on diets with adequate vitamin A. Three-way interactions among Cu, Zn, and vitamin A affected levels of retinol in serum and liver. Two-way interactions between Cu and vitamin A affected liver retinyl palmitate and the sum of liver retinol+retinyl palmitate. An independent effect of dietary Zn on these variables was also observed. Interactions between Cu and vitamin A affected levels of Cu in liver and kidney, while Fe and Zn in kidney were affected by interactions between Cu and Zn. This study demonstrates that differing interactions among variables of vitamin A metabolism and mineral status occur with higher dietary levels of vitamin A, Zn and Cu in the rat.


Subject(s)
Anticarcinogenic Agents/administration & dosage , Minerals/administration & dosage , Nutritional Status , Vitamin A/administration & dosage , Animals , Anticarcinogenic Agents/analysis , Anticarcinogenic Agents/metabolism , Ceruloplasmin/analysis , Copper/administration & dosage , Copper/analysis , Copper/metabolism , Diet , Diterpenes , Female , Liver/anatomy & histology , Liver/chemistry , Minerals/analysis , Minerals/metabolism , Organ Size , Rats , Rats, Sprague-Dawley , Retinyl Esters , Vitamin A/analogs & derivatives , Vitamin A/analysis , Vitamin A/metabolism , Zinc/administration & dosage , Zinc/analysis , Zinc/metabolism
12.
Nutr Cancer ; 21(1): 1-12, 1994.
Article in English | MEDLINE | ID: mdl-8183718

ABSTRACT

Various epidemiological and experimental studies have indicated that beta-carotene and vitamin E protect against a variety of cancers. This investigation determined whether a synergistic protective effect could be observed against chemically induced skin tumorigenesis in Skh mice by combining these two antioxidants in the diet. Forty-five mice were used in each of four diet groups. Control animals were fed standard mouse chow. Three other groups received the chow supplemented with one of the following: 0.5% beta-carotene, 0.12% vitamin E (added as d-alpha-tocopheryl succinate), or 0.5% beta-carotene + 0.12% vitamin E. Mice were topically treated with a single application of the initiator 7,12-dimethylbenz[a]anthracene and promoted with multiple applications of phorbol 12-myristate 13-acetate. Mice were observed for tumors each week for 27 weeks after initiation. The protective effect of each diet was determined by the decrease in the number of skin tumors in supplemented diet groups compared with that of the control diet group. Decreases in the number of cumulative tumors at Week 27 were 32% for beta-carotene-, 25% for vitamin E-, and 21% for beta-carotene+vitamin E-supplemented diet groups. However, differences in the number of tumors among the three groups supplemented with beta-carotene and/or vitamin E were not statistically significant. Thus, although protection was provided by the individual supplements, there was no synergistic effect for a decrease in the number of chemically induced skin tumors by the simultaneous dietary administration of beta-carotene and vitamin E.


Subject(s)
Carotenoids/pharmacology , Food, Fortified , Skin Neoplasms/prevention & control , Vitamin E/pharmacology , 9,10-Dimethyl-1,2-benzanthracene , Animals , Body Weight/drug effects , Carotenoids/metabolism , Female , Mice , Mice, Hairless , Prospective Studies , Skin Neoplasms/chemically induced , Skin Neoplasms/pathology , Trace Elements/metabolism , Vitamin E/metabolism , beta Carotene
13.
Agents Actions ; 37(3-4): 210-9, 1992 Nov.
Article in English | MEDLINE | ID: mdl-1284190

ABSTRACT

Minced von Ebner's glands of rat tongue were incubated in vitro with histamine and histamine receptor antagonists. At various time intervals, media and homogenates of the tissue were assayed for lingual lipase and amylase activity and percentage secretion calculated. Histamine elicited moderate secretion (approximately 10%) of lingual lipase and amylase. In contrast, pyrilamine, an H1 receptor antagonist, elicited > 60% secretion. There were statistically significant differences between the percentage secretion of lingual lipase and amylase for basal secretion, as well as for histamine- and pyrilamine-evoked secretion above basal. The H2 receptor inhibitors, cimetidine and ranitidine, stimulated secretion of only amylase, but not lingual lipase. When combined with histamine, these antagonists partially inhibited only the secretion of histamine-evoked lingual lipase, but not amylase. The differences in percentage secretion between the two enzymes indicate that exocytosis may not be the only process involved in protein secretion. The anomalous effects of the H1 and H2 receptor antagonists necessitate a more detailed characterization of the receptors of von Ebner's glands.


Subject(s)
Amylases/metabolism , Histamine H1 Antagonists/pharmacology , Histamine H2 Antagonists/pharmacology , Histamine/pharmacology , Lipase/metabolism , Salivary Glands/metabolism , Animals , Cimetidine/pharmacology , Exocytosis/drug effects , Male , Pyrilamine/pharmacology , Ranitidine/pharmacology , Rats , Rats, Sprague-Dawley , Salivary Glands/drug effects , Salivary Glands/enzymology
14.
Alcohol Clin Exp Res ; 15(4): 725-9, 1991 Aug.
Article in English | MEDLINE | ID: mdl-1928650

ABSTRACT

We have previously shown in rats that chronic ethanol feeding significantly inhibits the incorporation of labeled leucine into Apo E secreted into the liver perfusate (p less than 0.01). Fish oil has been shown to counteract many of the adverse effects of ethanol. In order to explore whether this inhibitory effect of ethanol was due to the decreased synthesis and/or defective glycosylation of this glycoprotein, we have determined the effects of chronic ethanol and fish oil on the synthesis and glycosylation of Apo E in vivo. Four groups of male Wistar rats were pair-fed the following liquid diets for 8 weeks; (1) Ethanol Regular Fat, (2) Control Regular Fat, (3) Ethanol Fish Oil, and (4) Control Fish Oil. At the end, the rats were intraportally injected with a single dose of [U-14C]leucine (0.2 microCi/g body weight) and/or [2-3H]mannose (1 microCi/g body weight) and killed after 30 min. The incorporation of the labeled precursors into the immunoprecipitable Apo E was measured in the liver and its microsomal and Golgi fractions. The results showed marked decreases in mannose incorporation into total glycoproteins and specifically of Apo E in whole liver, microsomal, and Golgi fractions under ethanol treatment. In contrast, the leucine incorporation into liver Apo E increased 11% (p less than 0.048) by ethanol treatment. As a result, the [3H]mannose/[14C] leucine incorporation ratio also decreased 41% to 47% at the whole liver, microsomal, and Golgi fractions indicating a marked inhibition in glycosylation of Apo E in the ethanol group.(ABSTRACT TRUNCATED AT 250 WORDS)


Subject(s)
Alcoholism/metabolism , Apolipoproteins E/metabolism , Liver/drug effects , Analysis of Variance , Animals , Apolipoproteins E/biosynthesis , Body Weight/drug effects , Fish Oils/pharmacology , Glycosylation/drug effects , Golgi Apparatus/drug effects , Leucine , Liver/metabolism , Male , Mannose , Microsomes, Liver/drug effects , Organ Size/drug effects , Rats , Rats, Inbred Strains
15.
J Pharmacol Exp Ther ; 258(1): 317-9, 1991 Jul 01.
Article in English | MEDLINE | ID: mdl-2072303

ABSTRACT

A single 20-microgram/kg dose of TCDD caused, within 3 days, a significant mobilization of depot fat into the plasma compartment resulting in 1.44- to 2.8-fold increase in plasma free-fatty acid concentrations. With respect to the fate of mobilized fatty acids, the same treatment of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) caused a 32% inhibition (P less than .008) of the rate of hepatic oleate oxidation without significantly affecting the rate of fatty acid esterification. In contrast, hepatic ketogenic rate from oleate and octanoate was stimulated markedly by 85% (P less than .001) and 69% (P less than .001), respectively. These results support the concept that although the beta-oxidation pathway of the fatty acids must be operating normally, their complete oxidation to CO2 via the Tricarboxylic acid (TCA) cycle is impaired. At the same time, TCDD seems to preferentially divert the acetyl CoA generated from the beta-oxidation of fatty acids to the ketogenic pathway. Surprisingly, TCDD treatment inhibited the hepatic ketogenic rate from glycerol by 21% (P less than .001) and its oxidation to CO2 by 31% (P less than .025) without affecting its esterification to triglycerides. These results imply that the other possible major site which is sensitive to TCDD inhibition may be the generation of acetyl CoA from glycerol via the pyruvate dehydrogenase complex.


Subject(s)
Fatty Acids/metabolism , Liver/drug effects , Polychlorinated Dibenzodioxins/pharmacology , Animals , Body Weight/drug effects , Eating/drug effects , Injections, Intraperitoneal , Liver/metabolism , Male , Oxidation-Reduction , Rats , Rats, Inbred Strains
16.
Alcohol Clin Exp Res ; 13(4): 554-9, 1989 Aug.
Article in English | MEDLINE | ID: mdl-2508507

ABSTRACT

The effects of 6 weeks of heavy and moderate ethanol feeding to rats upon lipids and lipoprotein metabolism were determined. As compared to the control group, the heavy ethanol feeding resulted in the following changes: liver weight/kilogram body weight increased by 48% (p less than 0.001) with a concomitant 52% increase (p less than 0.001) in liver protein/kilogram body weight and a 2.75-fold (p less than 0.001) increase in liver total lipids/kilogram body weight. In contrast, liver DNA/kilogram body weight or per liver was not affected significantly. Plasma cholesterol and triglycerides were higher by 53% (p less than 0.01) and 77% (p less than 0.01), respectively. Liver cholesterol and triglycerides were 4.4-fold and 3.8-fold higher (p less than 0.001), respectively. Plasma total A1 was 1.72-fold higher (p less than 0.001), whereas there was no significant difference in plasma apo E levels between the two groups. However, plasma high density lipoproteins (HDl) apo E was 48% lower (p less than 0.02) while the very low density lipoproteins (VLDL) E was 2.15-fold higher (p less than 0.02). Hepatic total protein synthetic rate in the ethanol group was not significantly different from the control group. In contrast, labeled leucine incorporation into the total secretory proteins was inhibited by 36% (p less than 0.01) in ethanol-fed group.(ABSTRACT TRUNCATED AT 250 WORDS)


Subject(s)
Alcoholism/blood , Apolipoproteins/blood , Lipoproteins, HDL/blood , Lipoproteins, VLDL/blood , Liver Diseases, Alcoholic/blood , Animals , Apolipoprotein A-I , Apolipoproteins A/blood , Apolipoproteins E/blood , Cholesterol/blood , DNA Replication/drug effects , Dose-Response Relationship, Drug , Ethanol/pharmacology , Liver/drug effects , Male , Organ Size/drug effects , Protein Biosynthesis , Rats , Rats, Inbred Strains , Triglycerides/blood
17.
J Lab Clin Med ; 113(5): 632-41, 1989 May.
Article in English | MEDLINE | ID: mdl-2497218

ABSTRACT

A sensitive, accurate, and reliable method is described for calibrating the rate immunonephelometric assay of rat and human plasma apolipoprotein A (Apo A). Pure Apo A and high-density lipoprotein (HDL) of known Apo A concentration were used in endpoint nephelometry to determine Apo A concentrations of rat and human plasma pools. The endpoint method had coefficients of variation of 7.96% and 4.35% for rat and human plasma pools, respectively. These plasma pools were then used as secondary standards for the rate nephelometric assay. Excellent agreement (+/- 6%) existed between the plasma Apo A values determined by endpoint nephelometry and rate nephelometry. The Apo A concentration of a frozen human plasma pool determined by endpoint nephelometry was 125.2 +/- 9.6 mg/dl. The value of the same pool determined by rate nephelometry over a 1-year period with the Centers for Disease Control WHO lyophilized plasma standard was 125.4 +/- 21.2 mg/dl. Furthermore, it was found that the rat HDL was also a suitable standard in the rate nephelometric assay of Apo A. In contrast, Apo A, purified to homogeneity, showed different reaction kinetics from that of Apo A in the whole plasma and therefore was not a suitable standard in the rate nephelometric assay. We therefore conclude that primary standard Apo A, purified to homogeneity, can be used by endpoint nephelometry to calibrate plasma pools that can then be used as secondary standards in the rate nephelometric determination of rat and human plasma Apo A. The ready applicability of this method in the accurate determination of plasma Apo A under well-defined experimental conditions such as in chronic ethanol-fed rats and in human subjects with normal lipid levels and those with hyperlipidemia is demonstrated.


Subject(s)
Apolipoproteins A/blood , Lipoproteins, HDL/blood , Animals , Apolipoprotein A-I , Cholesterol, HDL/blood , Electrophoresis, Polyacrylamide Gel , Humans , Nephelometry and Turbidimetry , Rats
18.
J Pharmacol Exp Ther ; 248(1): 62-6, 1989 Jan.
Article in English | MEDLINE | ID: mdl-2913289

ABSTRACT

A single i.p. administration of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) caused within 1 wk of exposure a dose-dependent progressive inhibition of liver fatty acid synthetic rate with concomitant decreases in hepatic fatty acid synthetase and acetylcoenzyme A carboxylase activities. Similarly, hepatic cholesterol synthetic rate was markedly inhibited with increasing dosage of TCDD, although the corresponding decrease in 3-hydroxy-3-methylglutaryl-coenzyme A reductase activity was of lesser magnitude. Linear regression analyses of the reciprocals of the responses versus the dose revealed that the TCDD concentration which caused 50% inhibition of the activities of various lipogenic enzymes and of lipid synthetic rates ranged from 11 to 20 micrograms/kg (34-67 nM) with an average of 15 micrograms/kg (47 nM). Hepatic cholesterol synthesis seemed to be more sensitive to inhibition than fatty acid synthesis whether it was based on TCDD dosage or duration of exposure. The degree of inhibition of all the above parameters except fatty acid synthesis in liver and adipose tissues increased from 1 to 2 wk of exposure but was less pronounced after 4 wk exposure. Significantly, the adipose tissue was found to be more sensitive than the liver with respect to inhibition of fatty acid synthesis by increasing dosage of TCDD. Thus, the biochemical mechanism of loss of adipose mass caused by TCDD exposure may well be mediated by strong inhibition of lipid synthesis in the adipose tissue coupled with increased mobilization of depot fat.


Subject(s)
Dioxins/toxicity , Lipids/biosynthesis , Polychlorinated Dibenzodioxins/toxicity , Adipose Tissue/drug effects , Adipose Tissue/metabolism , Animals , Body Weight/drug effects , Liver/drug effects , Liver/metabolism , Male , Organ Size/drug effects , Rats , Rats, Inbred Strains
19.
J Nutr ; 118(11): 1299-303, 1988 Nov.
Article in English | MEDLINE | ID: mdl-3193248

ABSTRACT

Relative effects of feeding ethanol and/or omega 3 fatty acid-rich fish oil for 6 wk on body lipids and lipoproteins were investigated. Ethanol increased plasma cholesterol (P less than 0.06) and triglycerides (P less than 0.0005), whereas fish oil decreased plasma cholesterol (P less than 0.005) and triglycerides (P less than 0.02). Liver cholesterol and triglycerides were increased by ethanol (P less than 0.0001) while fish oil decreased liver cholesterol (P less than 0.01) but not triglycerides. Based on Scheffé contrasts (P less than 0.05), fish oil blocked the increases in liver cholesterol and triglycerides caused by ethanol. Substitution of normal dietary fat with omega 3 fatty acid-rich fat in ethanol-fed animals lowered plasma cholesterol by 29% (P less than 0.001) and triglycerides by 30% (P less than 0.05) within 2 wk. Plasma apo A1 was increased by ethanol (P less than 0.001) and decreased by fish oil (P less than 0.002). Plasma total apo E was unaffected by either ethanol or fish oil. However, HDL apo E was decreased by ethanol (P less than 0.04) and increased by fish oil (P less than 0.02). Scheffé contrasts (P less than 0.05) also showed that plasma apo A was increased by ethanol regardless of whether the animals were consuming regular fat (1.72-fold) or fish oil fat (1.49-fold). Thus, omega 3 fatty acids can not only prevent but also reverse many of the lipid and lipoprotein abnormalities caused by alcohol abuse in the rat.


Subject(s)
Apolipoproteins A/blood , Apolipoproteins E/blood , Ethanol/pharmacology , Fish Oils/pharmacology , Lipid Metabolism , Liver/drug effects , Animals , Cholesterol/blood , Ethanol/administration & dosage , Lipids/blood , Liver/metabolism , Male , Rats , Rats, Inbred Strains , Triglycerides/blood
20.
Lipids ; 23(9): 904-6, 1988 Sep.
Article in English | MEDLINE | ID: mdl-3185127

ABSTRACT

The effects of 1, 5, 10 and 20 micrograms/kg dosages of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) upon de novo fatty acid and cholesterol synthesis in liver and adipose tissue were determined in pair-fed rats. The incorporation of tritium from 3H2O into tissue lipids was measured. Hepatic and adipose fatty acid synthetic rates (mumoles acetyl units g-1 hr-1) in the control groups were 19.6 +/- 4 and 75.7 +/- 18.5, respectively, and the liver cholesterol synthetic rate was 2.9 +/- 0.5. TCDD (1 microgram/kg) inhibited fatty acid synthesis in the liver and adipose tissue, by 44% and 41%, respectively, and the liver cholesterol synthesis was inhibited by 37%. The extent of these inhibitions increased with increasing dosages of TCDD. The effect of TCDD on sterol synthesis in adipose tissue could not be determined, because the tritium incorporation into the sterol fraction in this tissue was not detectable.


Subject(s)
Cholesterol/biosynthesis , Dioxins/pharmacology , Fatty Acids/biosynthesis , Polychlorinated Dibenzodioxins/pharmacology , Adipose Tissue/drug effects , Adipose Tissue/metabolism , Animals , Body Weight/drug effects , Liver/drug effects , Liver/metabolism , Organ Size/drug effects , Rats , Rats, Inbred Strains
SELECTION OF CITATIONS
SEARCH DETAIL